Wang Yu, Pan Kai-Feng, Lu Dao-Pei
Institute of hematology, The People Hospital of Peking University, Beijing 100044, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):9-15.
Monitoring engraftment of donor cells after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is supposed to be important for the early diagnosis of graft failure or relapse of malignancy. Several techniques have been reported for this purpose. PCR-based assays analyzing polymorphic short tandem repeats (STR) as markers are attractive because they are sensitive and can be performed rapidly. The intent of this study was to test a novel approach for assessment of donor engraftment using denaturing high-performance liquid chromatography (DHPLC) combined with STR-PCR. The feasibility of this assay and the accuracy of semi-quantitative results were tested in-vitro by using serial DNA mixtures from unrelated individuals. The results showed that dilution experiments of the mock chimerism sample revealed a clear correlation between the percentage of donor or recipient DNA and the proportion of allele peak areas, with the limit of detection for a minor DNA percentage being 5%. Discrimination between donor and recipient was possible in all patients analyzed (n = 51) except for 5 patients whose pre-transplant samples were not available and identical twins in one case. STR results were the same as values obtained by capillary electrophoresis combined with fluorescence labeling multiply PCR. Results were also compared with data obtained with FISH analysis in a subgroup of patients receiving grafts from sex-mismatched donors or with PCR-detectable disease-specific gene products analysis. The results of the microsatellite analysis correlated well with the corresponding clinical findings. Full donor chimerism (FDC) were detected in all patients; decreasing values of donor chimerism were detected concomitantly with the appearance of relapse of disease in 3 patients. Samples from eight patients receiving HLA mismatched-haploidentical transplants from related donors together with cord blood transplants from unrelated donors were analyzed by this method. The results showed all 8 patients achieved FDC derived from related donors. It is concluded that this novel approach allows a rapid, sensitive, economical, auto-mated and non-isotopic STR-PCR testing, thus provides a reliable alternative for assessment of the status of engraftment after allo-HSCT.
监测异基因造血干细胞移植(allo-HSCT)后供体细胞的植入情况对于早期诊断移植失败或恶性肿瘤复发至关重要。为此已报道了几种技术。基于聚合酶链反应(PCR)的分析多态性短串联重复序列(STR)作为标志物的检测方法很有吸引力,因为它们灵敏且能快速进行。本研究的目的是测试一种使用变性高效液相色谱(DHPLC)结合STR-PCR评估供体植入的新方法。通过使用来自无关个体的系列DNA混合物在体外测试了该检测方法的可行性和半定量结果的准确性。结果显示,模拟嵌合样本的稀释实验表明供体或受体DNA的百分比与等位基因峰面积比例之间存在明显相关性,次要DNA百分比的检测限为5%。除了5例移植前样本不可用的患者和1例同卵双胞胎患者外,所有分析的患者(n = 51)都能够区分供体和受体。STR结果与通过毛细管电泳结合荧光标记多重PCR获得的值相同。还将结果与在接受性别不匹配供体移植的患者亚组中通过荧光原位杂交(FISH)分析或通过PCR可检测的疾病特异性基因产物分析获得的数据进行了比较。微卫星分析的结果与相应的临床发现相关性良好。在所有患者中均检测到完全供体嵌合(FDC);在3例患者中,随着疾病复发的出现,同时检测到供体嵌合值降低。用该方法分析了8例接受来自相关供体的HLA不匹配单倍体移植以及来自无关供体的脐血移植的患者样本。结果显示所有8例患者均实现了源自相关供体的FDC。结论是,这种新方法允许进行快速、灵敏、经济、自动化且非同位素的STR-PCR检测,从而为评估allo-HSCT后的植入状态提供了一种可靠的替代方法。